Literature DB >> 20553986

Bilateral polymicrogyria as the indicative feature in a child with a 22q11.2 deletion.

Erica H Gerkes1, Roel Hordijk, Trijnie Dijkhuizen, Deborah A Sival, Linda C Meiners, Birgit Sikkema-Raddatz, Conny M A van Ravenswaaij-Arts.   

Abstract

Polymicrogyria (PMG) is a brain malformation due to abnormal cortical organisation. It is a heterogeneous disorder associated with 22q11.2 deletion syndrome (also known as velocardiofacial (VCF) syndrome) amongst others. Since this association was first recognised in 1996, over 30 patients with PMG and 22q11.2 deletion have been described. In 22q11.2 deletion syndrome, PMG is mainly located in the perisylvian areas; it frequently has an asymmetrical presentation with a striking predisposition for the right hemisphere. Neurological features of perisylvian PMG include developmental delay/mental retardation, seizures, microcephaly, spasticity and oromotor dysfunction. Thus in children diagnosed with 22q11.2 deletion syndrome, a finding of PMG has important prognostic value. We present a seven-month old boy with microcephaly, short stature and developmental delay. A cerebral MRI showed slightly enlarged ventricles and symmetrical perisylvian polymicrogyria. A 22q11.2 deletion was revealed by array-based comparative genomic hybridization. Remarkably the boy had no other manifestations of VCF syndrome. Paediatricians, child neurologists and clinical geneticists should be aware that the presence of PMG (especially in the perisylvian areas) needs investigating for 22q11.2 deletion, even if other more common VCF syndrome features are absent.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20553986     DOI: 10.1016/j.ejmg.2010.05.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  7 in total

Review 1.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

Review 2.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

3.  Aberrant Cortical Morphometry in the 22q11.2 Deletion Syndrome.

Authors:  J Eric Schmitt; Simon Vandekar; James Yi; Monica E Calkins; Kosha Ruparel; David R Roalf; Daneen Whinna; Margaret C Souders; Theodore D Satterwaite; Karthik Prabhakaran; Donna M McDonald-McGinn; Elaine H Zackai; Ruben C Gur; Beverly S Emanuel; Raquel E Gur
Journal:  Biol Psychiatry       Date:  2014-11-21       Impact factor: 13.382

4.  Bilateral polymicrogyria: always think in chromosome 22q11.2 deletion syndromes.

Authors:  Ana Castro; Nádia Rodrigues; Marco Pereira; Cláudia Gonçalves
Journal:  BMJ Case Rep       Date:  2011-11-23

5.  Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia.

Authors:  Andreas J Forstner; F B Basmanav; Manuel Mattheisen; Anne C Böhmer; Mads V Hollegaard; Esther Janson; Eric Strengman; Lutz Priebe; Franziska Degenhardt; Per Hoffmann; Stefan Herms; Wolfgang Maier; Rainald Mössner; Dan Rujescu; Roel A Ophoff; Susanne Moebus; Preben B Mortensen; Anders D Børglum; David M Hougaard; Josef Frank; Stephanie H Witt; Marcella Rietschel; Andreas Zimmer; Markus M Nöthen; Xavier Miró; Sven Cichon
Journal:  J Psychiatry Neurosci       Date:  2014-11       Impact factor: 6.186

6.  The Genetic Landscape of Polymicrogyria.

Authors:  Jesmy James; Mary Iype; Mithran Omana Surendran; Ayyappan Anitha; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2022-05-05       Impact factor: 1.714

7.  Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria.

Authors:  Samin A Sajan; Liliana Fernandez; Sahar Esmaeeli Nieh; Eric Rider; Polina Bukshpun; Mari Wakahiro; Susan L Christian; Jean-Baptiste Rivière; Christopher T Sullivan; Jyotsna Sudi; Michael J Herriges; Alexander R Paciorkowski; A James Barkovich; Joseph T Glessner; Kathleen J Millen; Hakon Hakonarson; William B Dobyns; Elliott H Sherr
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.